- Company Overview for CANADIAN PHARMA MIDDLE EAST LIMITED (12756449)
- Filing history for CANADIAN PHARMA MIDDLE EAST LIMITED (12756449)
- People for CANADIAN PHARMA MIDDLE EAST LIMITED (12756449)
- More for CANADIAN PHARMA MIDDLE EAST LIMITED (12756449)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
30 Mar 2021 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
12 Jan 2021 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
05 Jan 2021 | DS01 | Application to strike the company off the register | |
23 Nov 2020 | CH01 | Director's details changed for Professor Michael Stephen Johnson on 23 November 2020 | |
21 Nov 2020 | AP01 | Appointment of Professor Michael Stephen Johnson as a director on 21 November 2020 | |
21 Nov 2020 | TM01 | Termination of appointment of Tamer Mohammed Soliman as a director on 21 November 2020 | |
09 Nov 2020 | TM01 | Termination of appointment of Guy Rothschild as a director on 5 November 2020 | |
11 Aug 2020 | AP01 | Appointment of Mr Guy Rothschild as a director on 10 August 2020 | |
28 Jul 2020 | AP01 | Appointment of Mr Dominic Traynor as a director on 28 July 2020 | |
20 Jul 2020 | NEWINC |
Incorporation
Statement of capital on 2020-07-20
|